Martin B. Pedersen

Palle Juul Jensens Boulevard 99
Arhus, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial.

High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial.

Journal: Lancet (London, England)

Published: February 19, 2026

Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma.

Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma.

Journal: Hematology reports

Published: October 28, 2025

Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case Series.

Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case Series.

Journal: Acta dermato-venereologica

Published: June 06, 2024

Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.

Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.

Journal: Haematologica

Published: February 01, 2024

Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma.

Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma.

Journal: Haematologica

Published: June 21, 2023

Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.

Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.

Journal: Nature communications

Published: May 04, 2023

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia.

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia.

Journal: Cancers

Published: October 05, 2021

Echolocation click parameters of short-finned pilot whales (Globicephala macrorhynchus) in the wild.

Echolocation click parameters of short-finned pilot whales (Globicephala macrorhynchus) in the wild.

Journal: The Journal of the Acoustical Society of America

Published: March 26, 2021

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.

Journal: Case reports in hematology

Published: November 23, 2020

Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.

Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.

Journal: Haematologica

Published: November 28, 2019

High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS.

High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS.

Journal: Hematological oncology

Published: June 14, 2019

Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.

Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.

Journal: Blood

Published: March 25, 2019

Showing 1-12 of 25

Last Updated: 09/26/2026